Maple syrup. Health benefits
Riel-Roberge, G.èv.
Perspective Infirmiere Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 11(2): 62
2014
ISSN/ISBN: 1708-1890 PMID: 24672931 Document Number: 675338
Document emailed within 1 workday
Related Documents
Owada, M. 1978: Maple syrup urine disease Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl: 1342-1343Dambska, M. 1970: Neuropathology of the maple syrup disease Neuropatologia Polska 8(4): 349-355
Feng, K.P.; Chow, K.W.; Chan, Y.P. 1986: Maple syrup urine disease in Chinese Chinese Medical Journal 99(2): 119-120
Kovács, J. 1978: Mild variant of maple syrup disease Orvosi Hetilap 119(47): 2889-2892
Robinson, D.; Drumm, L.A. 2001: Maple syrup disease: a standard of nursing care Pediatric Nursing 27(3): 255-258; 261-264, 270
Pangkanon, S.; Charoensiriwatana, W.; Sangtawesin, V. 2008: Maple syrup urine disease in Thai infants Journal of the Medical Association of Thailand 91(Suppl 3): S41-S44
Chiemchanya, S.; Suthutvoravut, U.; Visudhiphan, P. 1989: Maple syrup urine disease: case report of 2 Thai infants Journal of the Medical Association of Thailand 72 Suppl. 1: 116-120
Potashnik, R.; Carmi, R.; Sofer, S.; Bashan, N.; Abeliovich, D. 1987: Maple syrup urine disease in a Bedouin tribe: pre- and postnatal diagnosis Israel Journal of Medical Sciences 23(8): 886-889
Statter, M.; Ben-Zvi, A.; Russell, A. 1976: Neonatal diagnosis of maple syrup urine disease and trial of exchange transfusion Harefuah 91(7): 167-169
Vulović, D.; Vilhar, N.; Hajduković, R.; Marjanović, B.; Stojanović, L. 1975: Disorders of leucine, isoleucine and valine metabolism (maple syrup urine disease) Srpski Arhiv Za Celokupno Lekarstvo 103(5): 419-436
Clow, C.L.; Reade, T.M.; Scriver, C.R. 1981: Outcome of early and long-term management of classical maple syrup urine disease Pediatrics 68(6): 856-862
Schuchmann, L.; Witt, I.; Schulz, P.; Schumacher, H.; Rüdiger, H. 1972: Multiple exchange transfusions as treatment during the acute period in maple syrup urine disease Helvetica Paediatrica Acta 27(4): 449-456
Machill, G. 1973: Results of screening studies for phenylketonuria, maple syrup disease and homocystinuria using Guthrie's test Kinderarztliche Praxis 41(5): 205-209
Stoppoloni, G.; Santinelli, R.; Prisco, F.; Tolone, C.; D'Ambrosio, M. 1978: Maple syrup urine disease: report of a mild variant case and results of dietary treatment La Pediatria 86(3): 409-420
Mofenson, H.C.; Caraccio, T.R. 1986: Benefits/risks of syrup of ipecac Pediatrics 77(4): 551-552
Simon, O.R.; Chang, C. 1994: Demonstration of bioequivalence between ventasol syrup and ventolin syrup in humans and in dogs West Indian Medical Journal 43(2): 39-42
Von Szeged, A.V.; Michos, N. 1986: Controlled single-blind clinical study of suprofen syrup versus metamizole syrup Arzneimittel-Forschung 36(7): 1110-1112
Heremans, G.; Dehaen, F.; Rom, N.; Ramet, J.; Verboven, M.; Loeb, H. 1988: A single-blind parallel group study investigating the antipyretic properties of ibuprofen syrup versus acetylsalicylic acid syrup in febrile children British Journal of Clinical Practice 42(6): 245-247
Karunathilake, I.M. 2012: Health changes in Sri Lanka: benefits of primary health care and public health Asia-Pacific Journal of Public Health 24(4): 663-671
2014: Basic health program: state administration of basic health programs; eligibility and enrollment in standard health plans; essential health benefits in standard health plans; performance standards for basic health programs; premium and cost sharing for basic health programs; federal funding process; trust fund and financial integrity. Final rule Federal Register 79(48): 14111-14151